Growth acceleration in children with chronic renal failure treated with growth-hormone-releasing hormone (GHRH)
Medicina (B.Aires)
; 56(3): 241-6, 1996. tab, graf
Article
en En
| LILACS
| ID: lil-181479
Biblioteca responsable:
BR1.1
ABSTRACT
Growth retardation is a prominent clinical manifestation in children with chronic renal failure (CRF). Nine children with CRF (3 on conservative treatment; 3 on dialysis and 3 after renal transplantation) aged 1.6 to 14.0 (x+ SE 8.1 + 1.4) years, were treated with twice daily subcutaneous injections of 26 + 2.4 mug/Kg/day growth-hormone-releasing-hormone [GHRH (1-29) NH2 Serono (Geref)] during 3 to 6 months. Mean serum urea and creatinine remained stable, although 2 patients on conservative treatment showed a moderate increase in serum creatinine. At the start of the study, heigth SDS was - 2.2 + 0.2 (x + SE), growth velocity was 4.5 + 1.0 cm/year (-2.3 + 0.6 DS for chronological age) and growth hormone (GH) response to acute GHRH test (1 mug/Kg IV) was 62 + 17.5 ng/ml. Five patients increased height velocity from 3.8 + 0.7 to 8.0 + 1.2 cm/year (paired t test, p < 0.05). The peak GH response to GHRH was significantly higher in the group of growth non-responders than in the responders (p<0.05). In conclusion, 5 out of 9 short children with CRF, 3 on conservative treatment, 1 on dialysis and 1 post renal transplantation, showed improved growth in response to GHRH therapy. No consistent effect on renal function was detected. GHRH may be an alternative therapy to increase grwth velocity in patients with CRF.
Buscar en Google
Índice:
LILACS
Asunto principal:
Hormona Liberadora de Hormona del Crecimiento
/
Insuficiencia Renal Crónica
/
Crecimiento
Límite:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Idioma:
En
Revista:
Medicina (B.Aires)
Asunto de la revista:
MEDICINA
Año:
1996
Tipo del documento:
Article